menu
    • menu

    Company profile for Bioxytran

    NEW Drugs in Dev: 5
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bioxytran is a company focused on developing treatments for stroke and Ischemia. More than 140,000 deaths occur each year due to stroke. Sign up to learn more about BioxyTran and join the fight, because when it comes to stroke, every second counts.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioxytranUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    233 Needham Street Suite 300 Newton, MA, 02464
    Telephone
    Telephone
    617-454-1199
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioxytraninc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioxytran-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioxytran Reports Positive Phase 1B/2A Results For Prolectin-M
    Bioxytran Reports Positive Phase 1B/2A Results For Prolectin-M

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/bioxytran-inc-reports-positive-phase-1b2a-clinical-study-results-for-prolectin-m-a-broad-range-a

    PHARMIWEB
    02 Mar 2026
    Share Share
    Bioxytran Shows Positive Ph2 Data for ProLectin-M Viral Clearance
    Bioxytran Shows Positive Ph2 Data for ProLectin-M Viral Clearance

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236066/0/en/Bioxytran-Reports-Positive-Phase-2-Results-Demonstrating-Rapid-Viral-Clearance-with-ProLectin-MBioxytran.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Bioxytran CEO To Present At Noble Capital Markets Conference
    Bioxytran CEO To Present At Noble Capital Markets Conference

    04 Feb 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bioxytran-ceo-david-platt-ph.d.-to-present-at-noble-capital-markets-emerging-growth-v-1133754

    ACCESSWIRE
    04 Feb 2026
    Share Share
    Bioxytran, University Of Minnesota Collaborate
    Bioxytran, University Of Minnesota Collaborate

    02 Feb 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bioxytran-and-university-of-minnesota-launch-sponsored-research-collaboration-to-adva-1131966

    ACCESSWIRE
    02 Feb 2026
    Share Share
    Bioxytran Highlights Momentum In Multi-Platform Pipeline Update
    Bioxytran Highlights Momentum In Multi-Platform Pipeline Update

    30 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-30/bioxytran-provides-corporate-update-highlighting-momentum-across-its-multi-platform-pipeline

    PHARMIWEB
    30 Jan 2026
    Share Share
    Bioxytran Advances Pipeline in Corporate Update
    Bioxytran Advances Pipeline in Corporate Update

    29 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bioxytran-provides-corporate-update-highlighting-momentum-across-its-multi-platform-p-1131467

    ACCESSWIRE
    29 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search